Outcomes in Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)

被引:0
|
作者
Katherin Zambrano-Vera
Armando Sardi
Carlos Munoz-Zuluaga
Kimberley Studeman
Carol Nieroda
Michelle Sittig
Mary Caitlin King
Arkadii Sipok
Vadim Gushchin
机构
[1] Mercy Medical Center,The Institute for Cancer Care
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:179 / 187
页数:8
相关论文
共 50 条
  • [21] Predictive Factors of Peritoneal Carcinomatosis from Appendiceal Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
    Jimenez, W. A.
    Sardi, A.
    Nieroda, C.
    Sittig, M.
    Nunez, M. F.
    MacDonald, R.
    Milovanov, V.
    Aydin, N.
    Gushchin, V.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S133 - S134
  • [22] Prognostic value of the volume time index (VTI) ratio for patients with appendiceal cancer with peritoneal carcinomatosis treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC).
    Karpes, Josh
    Dotta, Daniel
    Fisher, Oliver
    Shamavonian, Raphael
    Alzahrani, Nayef
    Morris, David L.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [23] Defining "Complete Cytoreduction" After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) for the Histopathologic Spectrum of Appendiceal Carcinomatosis
    Munoz-Zuluaga, Carlos A.
    King, Mary C.
    Diaz-Sarmiento, Victor S.
    Studeman, Kimberley
    Sittig, Michelle
    MacDonald, Ryan
    Nieroda, Carol
    Zambrano-Vera, Katherin
    Gushchin, Vadim
    Sardi, Armando
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (13) : 5026 - 5036
  • [24] Defining 'Complete Cytoreduction' After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) for the Histopathologic Spectrum of Appendiceal Carcinomatosis
    Munoz-Zuluaga, C. A.
    King, M.
    Diaz-Sarmiento, V. S.
    Sittig, M.
    Nieroda, C.
    Gushchin, V.
    Sardi, A.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S84 - S85
  • [25] Defining “Complete Cytoreduction” After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) for the Histopathologic Spectrum of Appendiceal Carcinomatosis
    Carlos A. Munoz-Zuluaga
    Mary C. King
    Victor S. Diaz-Sarmiento
    Kimberley Studeman
    Michelle Sittig
    Ryan MacDonald
    Carol Nieroda
    Katherin Zambrano-Vera
    Vadim Gushchin
    Armando Sardi
    Annals of Surgical Oncology, 2020, 27 : 5026 - 5036
  • [26] Importance of Anastomotic Site (AS) Resection during Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) in Patients with Peritoneal Carcinomatosis (PC) of Appendiceal Origin
    Aydin, N.
    Milovanov, V.
    Sittig, M.
    Gushchin, V.
    Sardi, A.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S175 - S175
  • [27] Peritoneal mestastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC)
    Falla-Zuniga, Luis Felipe
    Sardi, Armando
    King, Mary Caitlin
    Lopez-Ramirez, Felipe
    Barakat, Philipp
    Nieroda, Carol
    Diaz-Montes, Teresa
    Gushchin, Vadim
    PLEURA AND PERITONEUM, 2024, 9 (01) : 15 - 22
  • [28] Peritoneal Surface Disease (PSD) from Appendiceal Cancer Treated with Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Overview of 481 Cases
    Votanopoulos, K. I.
    Russell, G.
    Randle, R. W.
    Shen, P. W.
    Stewart, J. H.
    Levine, E. A.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S128 - S129
  • [29] Peritoneal Surface Disease (PSD) from Appendiceal Cancer Treated with Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Overview of 481 Cases
    Konstantinos I. Votanopoulos
    Greg Russell
    Reese W. Randle
    Perry Shen
    John H. Stewart
    Edward A. Levine
    Annals of Surgical Oncology, 2015, 22 : 1274 - 1279
  • [30] Peritoneal carcinomatosis arising from rectal or colonic adenocarcinoma treated with cytoreductive surgery (CRS) hyperthermic intraperitoneal chemotherapy (HIPEC): two different diseases
    Tonello, M.
    Ortega-Perez, G.
    Alonso-Casado, O.
    Torres-Mesa, P.
    Guinez, G.
    Gonzalez-Moreno, S.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (10): : 1268 - 1273